IS8356A - Lyfjasamsetningar, aðferðir og skammtastjórnun fyrir meðhöndlun og forvarnir á bráðum kransæðasjúkdómum - Google Patents

Lyfjasamsetningar, aðferðir og skammtastjórnun fyrir meðhöndlun og forvarnir á bráðum kransæðasjúkdómum

Info

Publication number
IS8356A
IS8356A IS8356A IS8356A IS8356A IS 8356 A IS8356 A IS 8356A IS 8356 A IS8356 A IS 8356A IS 8356 A IS8356 A IS 8356A IS 8356 A IS8356 A IS 8356A
Authority
IS
Iceland
Prior art keywords
medications
prevention
treatment
methods
heart disease
Prior art date
Application number
IS8356A
Other languages
English (en)
Inventor
L. Bisgaier Charles
V. Rodrigueza Wendi
D. Lalwani Narendra
Hartman Daniel
Johansson Jan
Original Assignee
Esperion Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2004/034800 external-priority patent/WO2005041866A2/en
Application filed by Esperion Therapeutics, Inc. filed Critical Esperion Therapeutics, Inc.
Publication of IS8356A publication Critical patent/IS8356A/is

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
IS8356A 2003-10-20 2006-03-16 Lyfjasamsetningar, aðferðir og skammtastjórnun fyrir meðhöndlun og forvarnir á bráðum kransæðasjúkdómum IS8356A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51311603P 2003-10-20 2003-10-20
PCT/US2004/034800 WO2005041866A2 (en) 2003-10-20 2004-10-19 Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes

Publications (1)

Publication Number Publication Date
IS8356A true IS8356A (is) 2006-03-16

Family

ID=37444404

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8356A IS8356A (is) 2003-10-20 2006-03-16 Lyfjasamsetningar, aðferðir og skammtastjórnun fyrir meðhöndlun og forvarnir á bráðum kransæðasjúkdómum

Country Status (5)

Country Link
CN (1) CN1870894B (is)
AP (1) AP2006003578A0 (is)
IS (1) IS8356A (is)
TN (1) TNSN06114A1 (is)
ZA (1) ZA200602248B (is)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6144276B2 (ja) * 2011-12-21 2017-06-07 シーエスエル、リミテッド アポリポタンパク質製剤のための投与計画
CN105483076B (zh) 2015-12-23 2019-01-25 中国科学院生物物理研究所 一种脂肪体的制备方法及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8625435D0 (en) * 1986-10-23 1986-11-26 Erba Farmitalia Human apolipoprotein ai
IT1229996B (it) * 1989-04-20 1991-09-20 Cesare Sirtori Espressione di apolipoproteina ai e apolipoproteina ai-milano in lievito e composizioni farmaceutiche che contengono dette apolipoproteine.
SE9603304D0 (sv) * 1996-09-11 1996-09-11 Pharmacia & Upjohn Ab Process for purifying a compound
WO2003026492A2 (en) * 2001-09-28 2003-04-03 Esperion Therapeutics Inc. Prevention and treatment of restenosis by local administration of drug

Also Published As

Publication number Publication date
ZA200602248B (en) 2007-09-26
CN1870894A (zh) 2006-11-29
TNSN06114A1 (fr) 2007-11-15
AP2006003578A0 (en) 2006-04-30
CN1870894B (zh) 2011-08-10

Similar Documents

Publication Publication Date Title
NO20053126D0 (no) Kontrollsystem for medisinsk behandling.
NO20050569D0 (no) Fremgangsmate for behandling av alvorlig hjertesvikt og medikament for dette
CY2014028I1 (el) Ενωσεις, φαρμακοτεχνικες μορφες και μεθοδοι θεραπειας ή αποτροπhς ροδοχρωμης ακμης
NO20053077D0 (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
NO20053041D0 (no) Behandling av diabetes.
NO20052760D0 (no) Fremgangsmate for behandling av kreft og beslektede fremgangsmater.
IS2722B (is) 1, 2, 3, 4- Tetrasetin indól til meðhöndlunar á öndunarfærasjúkdómum
EE200300212A (et) Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks
IS8142A (is) Læknislyf gagnleg til meðferðar á verkjum
IS7814A (is) Fenetanólamín afleiða í meðhöndlun á öndunarfærasjúkdómum.
NO20034590D0 (no) Fremgangsmåter for behandling av vaskul¶r sykdom
LTC1562603I2 (lt) Nauji vaistai, skirti lėtinių obstrukcinių plaučių ligų gydymui
NO20053817D0 (no) Preparater og fremgangsmater for antiviral kombinasjonsterapi.
NO20052855D0 (no) Fosfonoksykinazolinderivater og farmasoytisk anvendelse derav.
IS8071A (is) Aðferð við meðhöndlun á hnútahersli, fitudreyra og tengdum ástands tegundum og lyfjafræðilegum samsetningum
EP1745808A4 (en) MEDICAL MEDICAL FILTER MATERIAL AND TRAFFIC COLUMN AND EXTRACORPOREAL BLOOD FILTER USING THE SAME
IS7825A (is) Meðferðarfræðileg meðhöndlun
GB0201674D0 (en) Medical treatment
ATE389742T1 (de) Gewebebehandlungsmittel
IS7163A (is) Aðferðir til meðhöndlunar á lungnasjúkdómi
IS2487B (is) Asýloxýpýrrólidín afleiður, framleiðsla og meðferðarnotkun þar á
IS8356A (is) Lyfjasamsetningar, aðferðir og skammtastjórnun fyrir meðhöndlun og forvarnir á bráðum kransæðasjúkdómum
NO20055137D0 (no) Kombinasjon av et makrolid og et lokalbedovelsesmiddel for behandling av hudsykdommer
ITMO20030324A1 (it) Apparato medicale.
ITRM20020308A1 (it) Apparecchiatura per trattamenti terapeutici, e relativo metodo.